Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Eli Lilly deals a major blow to UK Mounjaro users, announcing a smaller KwikPen, the removal of a key 12.5mg dose, and a staggering 170% price increase, sparking outrage and access fears.
Groundbreaking research from Tufts University reveals that drugs like Ozempic and Wegovy are dramatically more effective for weight loss than traditional diet and exercise alone, potentially transforming the NHS's approach to the obesity epidemic.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
The NHS in England is set to provide the highly effective Mounjaro (tirzepatide) weight-loss injection, hailed as a major breakthrough in fighting obesity and related diseases like type 2 diabetes.
Jack Osbourne shuts down speculation he's using diabetes drug Ozempic for weight loss, revealing his dramatic 70lb transformation was achieved through hard work and discipline alone.
Health experts sound the alarm on a worrying new trend where individuals are microdosing powerful diabetes and weight-loss medications like Ozempic to shed pounds, despite severe health risks and a complete lack of evidence for its safety or efficacy.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
EXCLUSIVE: Tracey Cox exposes the hidden intimate costs of semaglutide injections. Discover why your marriage and sex life could be the ultimate price for rapid weight loss.
A nationwide manhunt is underway for a woman allegedly selling fake diabetes and weight-loss medications online. Authorities warn of severe health risks from counterfeit semaglutide injections.
UK health officials issue an urgent alert as a woman is hunted for selling counterfeit Mounjaro weight-loss injections online, posing a severe risk to public safety.
Groundbreaking UK study reveals a new diabetes medication, Mounjaro (tirzepatide), achieves significantly greater weight loss and superior cardiovascular benefits compared to Ozempic, revolutionising obesity treatment.
ITV's Dr Amir Khan reveals his four-stone transformation using diabetes drug Mounjaro, sparking a fierce debate among Lorraine viewers about medical ethics and weight loss solutions.
Groundbreaking British research warns that popular weight-loss injections like Ozempic and Mounjaro may significantly increase hospitalisation risks for heart failure patients. Experts call for urgent review of prescription guidelines.
Ex-Culture Minister Ed Vaizey urges the NHS to widely prescribe revolutionary weight loss injections, calling them a potential 'miracle' for public health and a solution to the obesity crisis.
Exclusive: Medical experts warn of a deepening postcode lottery and a surge in the illegal black market for weight-loss jabs as NHS England struggles with supply and soaring demand for GLP-1 drugs.
Groundbreaking UK research finds semaglutide-based drugs, popular for weight loss, significantly improve symptoms and physical limitations in obese heart failure patients, offering a new potential treatment avenue.
Eli Lilly drastically cuts the price of its Mounjaro injection in the UK, making the revolutionary diabetes and weight loss treatment more accessible. The move follows a landmark NHS supply deal.
The MHRA has officially approved the weight-loss injection Mounjaro (tirzepatide) for the UK market, with a set price, marking a significant new option in the nation's battle against obesity.
The weight loss drug Mounjaro (tirzepatide) is launching in the UK, challenging Ozempic. Experts warn of potential shortages and urge prescriptions for those with clinical need, not casual use.
An NHS weight loss expert explains the 'Ozempic burp' and other embarrassing gastrointestinal side effects of drugs like Mounjaro and Ozempic, why they happen, and practical strategies to manage them effectively.
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
The UK's medicines watchdog approves the weight loss injection Mounjaro (tirzepatide), offering a powerful new option in the fight against obesity. Discover its price, how it works, and where to get it.
A groundbreaking oral weight loss drug, Orforglipron, has demonstrated dramatic results in a recent clinical trial, offering a potential pill-based alternative to popular injectable treatments like Wegovy. The study shows significant weight reduction, spa
TV personality Ulrika Jonsson voices serious concerns over the rising trend of weight-loss injections, sparked by tennis icon Serena Williams' dramatic new physique, warning of a dangerous message being sent to women.
Tennis legend Serena Williams sparks conversation after sharing her use of GLP-1 medication for weight management, challenging stigma and highlighting the personal nature of health decisions.
Tennis legend Serena Williams and Reddit co-founder Alexis Ohanian endorse GLP-1 medications, advocating for their benefits while calling for reduced stigma and improved accessibility in weight management treatment.
A British woman's life-changing weight loss journey using Mounjaro injections has been thrown into turmoil after a dramatic price increase made the drug unaffordable, forcing her to confront the return of debilitating 'food noise'.
Scotland's NHS is spending a staggering £10 million annually on weight-loss injections like Ozempic and Wegovy as the nation battles a severe obesity epidemic. This investigative report reveals the soaring prescription costs and the pressing health challe
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.